SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-k
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 10, 2002
J. C. Penney Company, Inc.
(Exact name of registrant as specified in its charter)
Delaware 1-15274 26-0037077
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
of incorporation ) Identification No.)
6501 Legacy Drive
Plano, Texas 75024-3698
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (972) 431-1000
Item 5. Other Events and Regulation FD Disclosure
On July 10, 2002, the Florida Attorney General's Office announced the
resolution of its privacy investigation regarding Eckerd Corporation's patient
information programs. Without admitting any wrongdoing, Eckerd agreed to make
changes to its customer authorization procedures in connection with certain of
its patient information programs, and a $1 million donation to the Florida A&M
University School of Pharmacy to create an endowed chair faculty position.
Separately, the Florida Attorney General's Office has informed Eckerd that
it has closed its investigation into Eckerd's handling of metric decimal
quantity prescriptions without taking any action against Eckerd.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
J. C. PENNEY COMPANY, Inc.
(Registrant)
/s/ Charles R. Lotter
----------------------------
Charles R. Lotter
Executive Vice President,
Secretary andGeneral Counsel
Date: July 11, 2002